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SUMMARY 
 
Glaucoma in Africa is sometimes referred to as the silent thief of sight. In Nigeria, 
glaucoma is common, it is serious, ophthalmologists face many constraints in 
managing it, people do not even know they have it until it is advanced, patients do not 
understand or comply with treatment after they are diagnosed and the poor are more 
likely to be glaucoma blind. Available evidence indicates that the health system in 
Nigeria is failing to meet the needs of glaucoma patients. Based on evidence, we 
propose future directions for improving services for glaucoma care in Nigeria, and the 
implications for policy and programmes to control glaucoma blindness, using a health 
systems-oriented approach. Three complementary strategies are required: (i) 
strengthening clinical services for glaucoma – by developing models of glaucoma care, 
improving clinical treatment options, making medicines and equipment available, 
financing glaucoma care and training eye care workers; (ii) introducing initiatives for 
earlier detection of glaucoma in the clinic and approaches in the community; and (iii) 
strengthening health system governance. 
Glaucoma is a complex disease to manage and addressing it as a public health problem 
is challenging. However, we need to change the paradigm to recognise that glaucoma 
is a potentially avoidable cause of blindness in Africa. 
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INTRODUCTION  
 
The United Nations resolution on Universal Health Coverage (UHC) is fundamental to 
achieving Sustainable Development Goal no. 3 - equity in health for everyone. This 
entails not only improving access to quality health services but also protection against 
financial risks in accessing services.[1] In line with UHC, a Global Action Plan 2014-
2019 was developed for eye care,[2] which aims to ensure that eye diseases that cause 
blindness and visual impairment are addressed through universal standards of eye 
care that address local priorities.  
 
Glaucoma is a group of eye diseases characterised by progressive optic neuropathy 
with visual field loss which can lead to irreversible blindness. Glaucoma affected more 
than 64.3 million globally in 2013, and is projected to increase to 76 million by 
2020.[3] Primary open angle glaucoma (POAG) is the most common type, affecting 
57.5 million people in 2015, increasing to 65.5 million by 2020.[4] 
 
Glaucoma in Africa is sometimes referred to as the silent thief of sight,[5] and available 
evidence indicates that the health system in Nigeria is failing to meet the needs of 
glaucoma patients. Based on our findings[6-10] (summarised in Figure 1), we propose 
future directions for improving services for glaucoma care in Nigeria, and the 
implications for policy and programmes to control glaucoma blindness, using a health 
systems-oriented approach. Some of our recommendations also derive from major 
meetings on glaucoma in Africa: The Africa Glaucoma Summit in Accra, Ghana 
(2010)[11] and the Public Health Control of Vision Loss from Glaucoma in Africa 
Workshop in Kampala, Uganda (2012)[12] as well as relevant publications.[13, 14] The 
strategy we recommend is to target those in greatest need for glaucoma care to 
prevent them from going blind, supported by policies and funding mechanisms for 
service delivery, and clinical and operational research. At the same time, there is a 
need for health partnerships and social policies to address poverty through improved 
education and literacy, entrepreneurship and wealth creation.  
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GLAUCOMA IN NIGERIA 
 
Data from the 2009 Nigeria national blindness and visual impairment survey 
(thereafter referred to as the Nigeria Blindness Survey) indicated that 4.2% of adults 
aged 40 years and above were blind.[15] Glaucoma was the second commonest cause 
of blindness (16.7%),[16] principally open angle glaucoma (OAG) (86% of all 
glaucoma).[6] In 2009, 5% of survey participants had glaucoma, affecting an 
estimated 1.8 million adults, and one in five were blind i.e. had a presenting visual 
acuity (VA) of less than 3/60 in the better eye. Ninety-four per cent were not 
diagnosed and not receiving care.[6] Independent risk factors for OAG were higher 
intraocular pressure (IOP), increasing age and Igbo ethnicity.[7] People of low socio-
economic status were approximately four times more likely to be blind from 
glaucoma,[8] reflecting limited awareness of glaucoma and poor access to care. 
Additionally, ophthalmologists face many constraints in managing it.[9] 
 
From the Nigeria Blindness Survey, it is estimated that per million population, 10,500 
adults (aged 40 years and above) have glaucoma. The following definitions were used 
to estimate the number affected by level of severity, using the most affected eye: 
severe/advanced glaucoma – VA<3/60, vertical cup:disc ratio (VCDR) >0.8 and central 
visual field (CVF) of <10o; moderate glaucoma – any level of VA with VCDR>0.7 and 
CVF of 10-20o; early/mild glaucoma – any glaucomatous visual field defect and VCDR 
>0.7. Blind/end-stage glaucoma was defined as VA<3/60 in the better eye with a 
VCDR of 1.0.[17] There are estimated to be 5,900 (56%) adults per million population 
with severe/advanced disease, often blind in one eye and/or with severe visual 
impairment in the other eye, 2,100 (20%) moderate cases, 400 (4%) early cases and a 
further 2,100 (20%) are blind in both eyes.  
 
Several factors contribute to the high prevalence of glaucoma blindness in Nigeria. 
These include low rates of early detection and diagnosis,[17] lack of specialist 
equipment and treatment options, lack of specialist glaucoma clinics and care 
 5 
pathways, poor compliance with treatment and follow-up,[9] the high cost of 
accessing care and treatment costs,[18] and lack of awareness and public knowledge 
about glaucoma compounded by socioeconomic deprivation.[10] The number of eye 
health workers in Nigeria, including ophthalmologists and optometrists, falls short of 
World Health Organization recommendations.[19, 20] In addition, Nigeria does not 
have an eye health policy and the national strategic plan for eye care is not uniformly 
implemented. 
 
Considering these factors, three complementary strategies need to be put in place to 
reduce glaucoma blindness: (i) strengthening clinical services for glaucoma; (ii) 
introducing initiatives for earlier detection of glaucoma; and (iii) strengthening health 
system governance. 
 
 
STRENGTHENING CLINICAL SERVICES FOR GLAUCOMA 
 
Developing models of glaucoma care 
There are currently no published articles on models of glaucoma care in Africa. A 
conceptual framework and systems approach for improving services for glaucoma in 
Nigeria are shown in Figure 1. Clinical, operational and health system research need to 
be embedded in care delivery models to determine optimal ways to improve access 
and acceptance of cost-effective treatment, to improve patients’ hospital experiences 
and compliance rates, to promote follow-up of patients with stable disease in district 
eye departments, and for the earlier detection of glaucoma in the community.  
 
Improving clinical treatment options 
The treatment recommended for glaucoma in Africa depends on several factors. 
Medical therapy is often the first-line of treatment, with β-blockers and Prostaglandin 
analogues (PGAs) being available to prescribe by at least 97% of ophthalmologists in 
Nigeria.[9] PGAs are effective in preventing progression of visual field loss in the 
United Kingdom population,[21] but their use in Nigeria is limited due to their high 
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cost. Other constraints include poor compliance with medicines and uncertain 
potency of topical preparations, which are usually kept in high ambient temperatures. 
One-off interventions are recommended in Africa, one being primary trabeculectomy 
with antimetabolites or β-irradiation, with a suggested ‘glaucoma surgical rate’ of 800 
glaucoma surgeries per million population per year.[22] Indeed, skilful trabeculectomy 
with a joint care plan and adequate follow-up may be a good option but acceptance of 
surgery can be very low.[9, 17] Laser therapy seems a safe and acceptable alternative, 
which reduces costs to patients, as an inpatient stay is not required. Although the 
initial capital outlay for lasers is high, they can be used to treat other eye conditions, 
and can function for many years. An effective, safe, affordable and acceptable one-off 
treatment is the first essential building block of glaucoma care in Africa, particularly 
for the poor and illiterate and those who live far from eye care facilities. Treatment 
modalities need to be assessed in randomised controlled trials (RCTs) to determine 
the most cost-effective and acceptable treatment for patients and providers in the 
African context. 
 
Making medicines, surgery and laser treatment available 
To improve access to treatment, institutions need to be strengthened with equipment 
and training in surgical skills and laser procedures, with the development of glaucoma 
care teams. Tertiary institutions should have specialist glaucoma clinics which are 
adequately resourced so that a full assessment and definitive diagnosis can be made at 
the first visit, with counselling of patients and their carers about treatment and the 
need for long-term follow-up.  
 
Relevant government ministries/agencies are urged to improve the supply chain of 
glaucoma medications and surgical consumables through tax and import duty waivers, 
and by providing an enabling environment for local production of glaucoma 
medication. Pharmaceutical companies could be called upon to provide non-branded 
PGAs which may be made affordable and provided free of charge to the poorest 
through government’s UHC mechanisms, and global technology partners should make 
lasers and accessories (lenses, probes, protective goggles, etc.) more affordable for 
service providers in low/middle income countries.  
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Financing glaucoma care 
No patient should receive suboptimal care because they cannot afford treatment. 
Strategies for healthcare financing for glaucoma to contain costs need to be developed 
and evaluated. One approach could be to provide free treatment to poor patients. 
Another is to advocate that more potent medications such as PGAs, and 
trabeculectomy and laser procedures be covered by health insurance. UHC through 
government budgetary allocations is probably the most sustainable approach for such 
a chronic, serious and life-long disease.  
 
Human resources for eye health 
In order to improve services for glaucoma, multi-tasking by health workers is 
recommended with, for example, nurses being trained to perform optic nerve head 
photography and visual field analysis. Early detection of significant glaucoma through 
community-based opportunistic case-detection by optometrists, follow-up in the 
community and community-based care especially for post-operative cases by 
ophthalmic nurses, and testing for vision loss by primary healthcare workers are also 
strategies to explore. Agreement on professional boundaries will be required, with 
clearly defined work areas for allied eye care members of the glaucoma care team, and 
clearly defined roles for glaucoma care in secondary centres.[23] 
 
Health information system 
Health management information systems are essential for improving glaucoma 
services in Nigeria to provide good medical records systems to track patients over time 
and monitor trends of treatment. We recommend that the number of procedures for 
glaucoma, as well as the number of cataract operations, be monitored and reported 
centrally. Good medical records are also important for robust referral/feedback 
systems, to document clinical findings for follow-up and to develop a database of 
glaucoma patients.  
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APPROACHES FOR EARLIER DETECTION OF GLAUCOMA 
 
Before starting any intervention for case-detection, adequate clinical services for 
glaucoma must be in place. The challenge of a public health glaucoma care 
programme would be to find people who already have significant glaucoma and 
ensure they have access to services to reduce the risk of progression to bilateral 
blindness. The poorest in the population need to be targeted because glaucoma 
blindness affects them the most.  
 
In the clinic 
Primary eye care, including that provided by optometrists who are few in number and 
usually  located in urban areas,  is almost entirely lacking in Nigeria, as in many 
countries in Africa, and so there are no mechanisms for early detection of glaucoma. 
One solution to improve earlier detection of glaucoma is to ensure that all adults aged 
40 years and above who present to eye care services, regardless of their presenting 
complaint, undergo routine optic disc assessment. This approach was effective in the 
eye department in Bauchi, North-eastern Nigeria, where the optometrists referred 
anyone with a CDR >0.6 to the ophthalmologist for examination.[17]     
 
Identified high-risk groups and first-degree relatives (FDRs) of patients with glaucoma 
should also be targeted.  
 
Community approaches 
We advocate that optic disc assessment of all those aged 40 years and above become 
an integral component of outreach eye care activities with a referral of those with 
VCDR>0.6 to designated facilities for full assessment, definitive diagnosis and 
treatment. Another assessment to consider at the community level is a properly 
conducted swinging flashlight test to detect relative afferent pupillary defects (RAPD) 
which has to the potential to find at least 25% of glaucoma,[24] and with strong 
specificity for glaucoma.[25]  
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Figure 2 shows a possible algorithm for glaucoma case-detection at community and 
clinic levels. In a retrospective evaluation of outreach in Ibadan, people referred from 
outreach were twice as likely to have mild/moderate glaucoma than patients referred 
from other facilities who had more severe disease.[26]  
 
Another strategy is to integrate optic disc imaging using mobile phone apps into 
screening activities for non-communicable diseases, or into programmes for the 
control of onchocerciasis (river blindness) and trachoma, which are reaching a high 
proportion of the most vulnerable population in Nigeria. 
 
Informal providers of healthcare, who are ubiquitous and acceptable to community 
members in Africa, could also be engaged in identifying individuals suspected of 
having glaucoma. For example, in Nassarawa, spectacle vendors were enrolled in a 
study to assess interventions for finding cases of glaucoma in the community. About 
half of those referred by spectacle vendors subsequently attended the eye clinic, 15% of 
whom were newly diagnosed with glaucoma. (Personal communication: HI, MSc 
PHEC dissertation, LSHTM 2016). 
  
Other approaches for earlier detection may include designing and implementing a 
community awareness strategy, using local terms such as those in Hausa that describe 
behaviour associated with peripheral visual field loss (e.g. taka shanya), through social 
and mass media platforms  such as radio which has a wide reach, television, and 
newspapers. For example, people could be encouraged to regularly check the vision of 
each eye by covering the other eye. Community awareness strategies should be 
planned carefully to avoid creating a demand that cannot be met. However, greater 
demand is needed to generate political pressure that may drive the development of 
better services.  
 
 
STRENGTHENING HEALTH SYSTEMS GOVERNANCE 
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A strong health system requires leadership and governance to deliver improved care, 
based on evidence of what works, as day-to-day monitoring and interval evaluation 
can improve services. Additionally, it is important that team leaders take part in 
developing policies to include glaucoma in national healthcare plans and to integrate 
eye care into programmes for non-communicable diseases. Data and information are 
also required for advocacy with policy makers and for the engagement of civil society 
to improve health education, knowledge and public awareness. 
 
Glaucoma patients’ associations can be strengthened to support vulnerable groups 
through sharing experiences and resources by patients and family advocates.  
 
 
CONCLUSION 
 
Glaucoma is a complex disease to manage and addressing it as a public health problem 
is a challenge. However, we need to change the paradigm to recognise that glaucoma 
is a potentially avoidable cause of blindness in Africa. We have discussed possible 
ways in which to improve services for glaucoma in Nigeria with the aim of ensuring 
inclusion of those most at risk of blindness from glaucoma i.e. the poor. Further 
clinical and operational research is required to address the acknowledged evidence 
gaps. We also advocate for policies to make glaucoma treatment available and 
affordable to all, and possibly free to the poor. Rather than remaining silent, let us give 
glaucoma patients a voice so that the silent thief of sight does not lead them into 
darkness. 
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 FIGURES 
 
Figure 1. Conceptual framework for improving services for glaucoma in Nigeria 
 
Figure 2. Algorithm for glaucoma case-detection at community and clinic levels by 
assessment of cup:disc ratio and relative afferent pupillary defect 
 
 
  
 
